Key result
Implantation of a new sutureless aortic valve (Perceval Sorin) was feasible in 16 high-risk patients, resulting in no paravalvular leakage and a median cross-clamping time of 36 minutes.
Why the study?
Does a sutureless aortic valve implanted via an open approach demonstrate feasibility and safety in high-risk patients with significant aortic valve disease?
Population
16 high-risk patients with significant aortic valve disease, median age 81, 13 females, Euro Score 17.
Design
Case_series
Follow-up
In-hospital
Authors
Loading...
Should not yet change practice in high-risk aortic valve replacement; leaves open the role of sutureless valves pending prospective trials.
Does a sutureless aortic valve implanted via an open approach demonstrate feasibility and safety in high-risk patients with significant aortic valve disease?
Initial human implants of a new sutureless aortic valve via an open approach demonstrated feasibility, short cross-clamp times, and excellent immediate hemodynamic performance without paravalvular leak.
Shrestha et al. (2008) studied significant aortic valve disease (n=16). Sutureless aortic valve (Perceval Sorin) was evaluated on feasibility of implantation. Implantation of a new sutureless aortic valve (Perceval Sorin) was feasible in 16 high-risk patients, resulting in no paravalvular leakage and a median cross-clamping time of 36 minutes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: